Search research articles
Contact Us
Filters
Showing results (1-10 of 63) with videos related to
Page
of 7
Sort By:
Cancers
|
November 27, 2021
Advantages and Challenges of Using ctDNA NGS to Assess the Presence of Minimal Residual Disease (MRD) in Solid Tumors
Lionel Larribère, Uwe M Martens
Current Molecular Medicine
|
June 25, 2005
Telomere dynamics in hematopoietic stem cells
Stefan Zimmermann, Uwe M Martens
Cell and Tissue Research
|
October 26, 2007
Telomeres, senescence, and hematopoietic stem cells
Stefan Zimmermann, Uwe M Martens
Methods in Molecular Biology (Clifton, N.J.)
|
March 29, 2008
Telomerase inhibition and telomere targeting in hematopoietic cancer cell lines with small non-nucleosidic synthetic compounds (BIBR1532)
Hesham El Daly, Uwe M Martens
Langenbeck'S Archives of Surgery
|
February 22, 2015
Personalized treatment for colorectal cancer: novel developments and putative therapeutic strategies
Jamil Akkad, Sylvia Bochum, Uwe M Martens
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
August 3, 2018
Larotrectinib (LOXO-101)
Stephanie Berger, Uwe M Martens, Sylvia Bochum
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
August 3, 2018
Olaparib
Sylvia Bochum, Stephanie Berger, Uwe M Martens
Studies in Health Technology and Informatics
|
September 1, 2016
Clinical Cancer Registries - Are They Up for Health Services Research?
Monika Pobiruchin, Sylvia Bochum, Uwe M Martens, et al.
International Journal of Oncology
|
April 6, 2005
The level of telomere dysfunction determines the efficacy of telomerase-based therapeutics in a lung cancer cell line
Milena Pantic, Stefan Zimmermann, Cornelius F Waller, et al.
Journal of Biomedical Informatics
|
February 9, 2016
A method for using real world data in breast cancer modeling
Monika Pobiruchin, Sylvia Bochum, Uwe M Martens, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 63) with videos related to
Sort By:
Page
of 7
Cancers
|
November 27, 2021
Advantages and Challenges of Using ctDNA NGS to Assess the Presence of Minimal Residual Disease (MRD) in Solid Tumors
Lionel Larribère, Uwe M Martens
Current Molecular Medicine
|
June 25, 2005
Telomere dynamics in hematopoietic stem cells
Stefan Zimmermann, Uwe M Martens
Cell and Tissue Research
|
October 26, 2007
Telomeres, senescence, and hematopoietic stem cells
Stefan Zimmermann, Uwe M Martens
Methods in Molecular Biology (Clifton, N.J.)
|
March 29, 2008
Telomerase inhibition and telomere targeting in hematopoietic cancer cell lines with small non-nucleosidic synthetic compounds (BIBR1532)
Hesham El Daly, Uwe M Martens
Langenbeck'S Archives of Surgery
|
February 22, 2015
Personalized treatment for colorectal cancer: novel developments and putative therapeutic strategies
Jamil Akkad, Sylvia Bochum, Uwe M Martens
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
August 3, 2018
Larotrectinib (LOXO-101)
Stephanie Berger, Uwe M Martens, Sylvia Bochum
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
August 3, 2018
Olaparib
Sylvia Bochum, Stephanie Berger, Uwe M Martens
Studies in Health Technology and Informatics
|
September 1, 2016
Clinical Cancer Registries - Are They Up for Health Services Research?
Monika Pobiruchin, Sylvia Bochum, Uwe M Martens, et al.
International Journal of Oncology
|
April 6, 2005
The level of telomere dysfunction determines the efficacy of telomerase-based therapeutics in a lung cancer cell line
Milena Pantic, Stefan Zimmermann, Cornelius F Waller, et al.
Journal of Biomedical Informatics
|
February 9, 2016
A method for using real world data in breast cancer modeling
Monika Pobiruchin, Sylvia Bochum, Uwe M Martens, et al.
Page
of 7